A Retrospective Study on Maternal and Fetal Outcomes in Premature Rupture of Membranes
DOI:
https://doi.org/10.52783/jns.v14.2495Keywords:
Premature rupture of membranes, maternal morbidity, neonatal sepsis, chorioamnionitis, NICU admissions, term PROM, labour inductionAbstract
Background: Premature rupture of membranes (PROM) at term (≥37 weeks) complicates 8–10% of pregnancies and is associated with increased maternal and neonatal morbidity. The optimal management strategy—expectant management versus immediate induction—remains debated. Prolonged PROM (>24 hours) has been linked to increased risks of chorioamnionitis, postpartum haemorrhage, neonatal sepsis, and NICU admissions. This study evaluates maternal and fetal outcomes in PROM cases to guide clinical decision-making.
Methods: This hospital-based retrospective study was conducted at Chettinad Health and Research Institute, Tamil Nadu, India, analysing medical records of 100 women diagnosed with PROM at ≥37 weeks gestation (January 1, 2023 – December 31, 2023). Data included maternal demographics, mode of delivery, time from PROM to delivery, maternal complications, and neonatal outcomes. Statistical Analysis: Descriptive statistics, Chi-square tests, logistic regression, Pearson correlation, and Kaplan-Meier survival analysis were performed using SPSS v26.0. A p-value <0.05 was considered statistically significant.
Results: Maternal Outcomes: 72% delivered vaginally, while 28% required cesarean delivery due to fetal distress (11%), failure to progress (9%), and chorioamnionitis (5%). The mean latency period from PROM to delivery was 12.8 ± 5.6 hours. Chorioamnionitis (7%) was the most common maternal complication, significantly increasing when PROM lasted >24 hours (29% vs. 3%, p=0.004). Neonatal Outcomes: 16% required NICU admission, primarily due to respiratory distress syndrome (8%) and neonatal sepsis (6%). Prolonged PROM was significantly associated with a 5.2-fold higher risk of NICU admission (p=0.002) and a 4.7 times increased risk of neonatal sepsis (p=0.001). Perinatal mortality was 2%. Negative correlation between PROM duration and APGAR scores (r=-0.58 at 1 min, p<0.001). Kaplan-Meier analysis showed higher neonatal morbidity with PROM >24 hours (p<0.001, log-rank test).
Conclusion: Prolonged PROM (>24 hours) significantly increases maternal infections and neonatal morbidity, including higher NICU admissions and neonatal sepsis risk. Timely labour induction within 12 hours may reduce these complications, supporting proactive management strategies over expectant management. Future studies should focus on optimal timing for labour induction in terms of PROM and infection prevention strategies to improve maternal and neonatal outcomes.
Downloads
Metrics
References
Middleton P, Shepherd E, Flenady V, McBain RD, Crowther CA. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev. 2017;1:CD005302 . doi: 10.1002/14651858.CD005302.pub3. PMID: 28050901.
Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol. 2008;1(1):11-22. PMID: 18701961; PMCID: PMC2505167.
van der Ham DP, van der Heijden J, van Kuijk S, Opmeer BC, van Beek JH, Mol BW, et al. Management of late preterm and term premature rupture of membranes: a prospective randomised comparison of immediate induction versus expectant management (PPROMEXIL trial). Eur J Obstet Gynecol Reprod Biol. 2012;163(1):15-21. doi: 10.1016/j.ejogrb.2012.03.023. PMID: 22525081.
Morris JM, Roberts CL, Bowen JR, Patterson JA, Bond DM, Algert CS, et al. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet. 2016;387(10017):444-452. doi: 10.1016/S0140-6736(15)00724-2. PMID: 26597166.
Jairam VK, Sudha S. A study of premature rupture of membranes management and outcome. J Obstet Gynecol India. 2001;51(2):58-60.
Mercer BM, Lewis R. Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstet Gynecol Clin North Am. 2020;47(4):623-638. doi: 10.1016/j.ogc.2020.08.003. PMID: 33121649.
Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010;37(2):339-354. doi: 10.1016/j.clp.2010.02.003. PMID: 20569811; PMCID: PMC3008318.
Waters TP, Mercer BM. The management of preterm premature rupture of the membranes near the limit of fetal viability. Am J Obstet Gynecol. 2009;201(3):230-240. doi: 10.1016/j.ajog.2009.06.049. PMID: 19733274.
Boyle AK, Rinaldi SF, Norman JE, Stock SJ. Preterm birth: inflammation, fetal injury, and treatment strategies. J Reprod Immunol. 2017;119:62-66. doi: 10.1016/j.jri.2016.11.008. PMID: 27914271.
Sotiriadis A, Papatheodorou S, Kavvadias A, Makrydimas G. Transvaginal cervical length measurement for predicting preterm birth in women with threatened preterm labour: a meta-analysis. Ultrasound Obstet Gynecol. 2010;35(1):54-64. doi: 10.1002/uog.7457. PMID: 20014355.
Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2013;12:CD001058 . doi: 10.1002/14651858.CD001058.pub3. PMID: 24307514.
Ghidini A, Salafia CM. Histologic placental lesions in women with preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2005;18(1):3-8. doi: 10.1080/14767050500217863. PMID: 16105785.
Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, et al. Predictors of neonatal outcomes in pregnancies with preterm premature rupture of membranes. Am J Perinatol. 2016;33(9):840-848. doi: 10.1055/s-0036-1572434. PMID: 26901473.
Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84. doi: 10.1016/S0140-6736(08)60074-4. PMID: 18177778.
Mackeen AD, Seibel-Seamon J, Grimes-Dennis J, Baxter JK, Berghella V. Tocolytics for preterm premature rupture of membranes. Cochrane Database Syst Rev. 2011;10:CD007062. doi: 10.1002/14651858.CD007062.pub2. PMID: 21975761.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.